MYCN and neuroblastoma: Conversely, our group has demonstrated that a subset of high-risk MYCN-not-amplified (MYCNNA) neuroblastomas have increased T-cell infiltration, suggesting the presence of antigenic targets and an active anti-tumor immune response [11,12].